Foslevodopa is a water-soluble prodrug of levodopa, an L-tyrosine derivative used in the management of Parkinson's disease. It is designed for continuous subcutaneous infusion to provide stable levodopa levels in advanced Parkinson's.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Foslevodopa?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Cephapirin benzathine
pharmaceutical raw material
S-adenosyl-L-methionine disulfate tosylate
pharmaceutical raw material
6,7-dihydrocanrenone
pharmaceutical raw material
Canrenone
pharmaceutical raw material
The international HS code for Foslevodopa (CAS 97321-87-4) is 2922.50.
2922.50
2922 50 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S)-2-amino-3-(3-hydroxy-4-phosphonooxyphenyl)propanoic acid
YNDMEEULGSTYJT-LURJTMIESA-N
C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)OP(=O)(O)O
Sourcing Foslevodopa?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.